Stem cell and induced pluripotent stem cell companies develop cells, therapies and research platforms capable of modelling development, disease and tissue regeneration. Their technologies support drug discovery, regenerative medicine, toxicology and advanced therapeutic development.
This category includes companies working on:
Browse 46 UK stem cell and iPSC companies below.
Rotating wall bioreactors simulating microgravity for cell and crystal research
Microgravity Bioreactors develops rotating-wall laboratory systems that simulate aspects of microgravity on Earth. The vessels keep cells and crystals suspended while limiting sedimentation and shear stress, allowing researchers to explore experimental conditions before committing samples to space-based studies. Its…
Human iPSC platform for neurodegenerative disease drug discovery
Talisman Therapeutics is a drug discovery company specialising in human induced pluripotent stem cell (iPSC) models of neurodegenerative disease. The company operates both an internal discovery pipeline, focused on Alzheimer's disease targets including lysosome biology, pathogenic protein reduction and microglial…
Stem-cell disease models and multi-omics toxicology platforms
Stemnovate is a Cambridge biotechnology company developing human stem-cell models and multi-omics platforms for drug discovery and toxicology. Its induced pluripotent stem cell biobank supports reprogramming, differentiation and the development of disease-relevant cellular models. Genomic, transcriptomic, proteomic…
Life science reagents supplier and flow cytometry stabilisation manufacturer
Caltag is an employee-owned supplier of research, clinical and diagnostic reagents to laboratories across the UK and Ireland. It distributes antibodies, assay kits, cells and tissues, nucleic acid tools, proteins and consumables from specialist manufacturers worldwide. The company also manufactures a cell…
Real-time cell aggregate monitoring for stem cell manufacturing
MorphoKinetics is a life science instrumentation company developing real-time monitoring technology for stem cell manufacturing. Its process analytical platform combines automated sampling, machine vision and artificial intelligence to measure the size, shape and growth of cell aggregates in bioreactor cultures. The…
Genetically diverse iPSC models and high-throughput drug screening
Cytochroma is an Edinburgh biotechnology company producing genetically diverse human induced pluripotent stem cell-derived models for drug discovery and safety research. Its donor-matched panels include hepatocytes, cardiomyocytes and supporting cell types, enabling assessment of drug responses across different…
Automated single-cell isolation and cloning instruments for cell biology
Iota Sciences is a developer of automated single-cell handling instruments and cell-line engineering services. The company's platform automates single-cell isolation and cloning in nanolitre volumes, supporting monoclonal cell line development with integrated viability monitoring and documentation. GRID Technology…
High-throughput iPSC reprogramming and stem cell drug discovery services
Oxford StemTech is a contract research company providing induced pluripotent stem cell (iPSC) reprogramming and drug discovery services using its proprietary platform. The technology enables large-scale, cost-effective generation of patient-derived iPSC lines from blood or skin samples, supporting disease modelling,…
Biomedical discovery institute researching the molecular basis of disease
The MRC Laboratory of Medical Sciences is a biomedical discovery research institute studying the molecular and physiological basis of health and disease. Scientists and clinicians collaborate across three core research areas, including epigenetics and stem cell development, genes and metabolism, and quantitative…
Human iPSC-derived disease models and drug discovery services
Axol Bioscience is a biotechnology company supplying human induced pluripotent stem cell-derived cells and research services for disease modelling and drug discovery. Its portfolio includes neurons, cardiomyocytes, retinal organoids, retinal pigment epithelium and skin cell models, alongside culture media and custom…
Combinatorial stem cell screening platform for therapy development
Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial screening to test thousands of cell culture variable combinations in parallel, identifying optimised protocols for stem cell expansion,…
Automated robotic systems for cell therapy and stem cell manufacture
Sakarta is an instruments and equipment company developing automated robotic solutions for cell therapy and stem cell manufacturing. Working with partners in the UK and Japan, it is commercialising a closed automated cell culture instrument incorporating real-time process analytical technology. The platform automates…
Ex vivo haematopoietic stem cell gene therapies for rare genetic diseases
Orchard Therapeutics is a gene therapy company developing ex vivo haematopoietic stem cell therapies for rare genetic diseases, primarily severe neurometabolic and immunological disorders in children. Its platform modifies a patient's own stem cells with a functional copy of the defective gene before reinfusion. Lead…
Automated bioreactor platform for GMP cell therapy manufacturing
Aglaris is a developer of automated cell manufacturing systems for advanced therapy medicinal products. Its flagship platform integrates real-time process monitoring, single-use culture cartridges, and GMP-compliant controls to enable reproducible production of CAR-T cells, mesenchymal stem cells, and other cell types…
University research institute advancing stem cell biology and therapeutics
Cambridge Stem Cell Institute is a University of Cambridge research institute investigating stem cell biology, tissue maintenance and disease. Its research groups study stem cell states, disease mechanisms and therapeutic applications using cell culture, genomics, imaging and experimental models. Based at Cambridge…
Precision-programmed human iPSC-derived cells for biomedical research
bit.bio is a Cambridge-based synthetic biology company that programmes human induced pluripotent stem cells into defined, mature cell types for use in pharmaceutical and academic research. Its precision cell programming technology produces consistent, characterised human cells at industrial scale, supporting drug…
Rejuvenation biology company decoding the genomics of cellular ageing reversal
clock.health is a biotechnology company developing therapies to reverse cellular ageing and extend healthspan by decoding the biological programmes that govern cell rejuvenation. Using a proprietary model in which human induced pluripotent stem cells are artificially aged then permitted to self-rejuvenate, the company…
Cell and gene therapy CDMO with clinical and commercial manufacturing
RoslinCT is a CDMO specialising in advanced cell and gene therapies. Operating purpose-built cGMP facilities at Edinburgh BioQuarter and in Hopkinton, Massachusetts, it provides process development, analytical testing, clinical and commercial manufacturing for autologous and allogeneic cell therapies, with particular…
Causal cellular data and AI models for drug discovery
CellCodex is a biotechnology company that generates causal data from human cells to train predictive models for drug discovery. It programmes stem cells into pure, aged, disease-relevant cell types, perturbs them at genome scale with CRISPR and compounds, and reads the outcome in single cells. The company applies the…
Macrophage-targeted therapeutics for oncology, neurological and fibrotic diseases
Macomics is a University of Edinburgh spin-out developing macrophage-targeted medicines across oncology, neurodegenerative, inflammatory and fibrotic diseases. Its ENIGMAC drug discovery platform combines human macrophage and microglia models derived from induced pluripotent stem cells, gene editing and…